SCOPUS 정보 검색 플랫폼

Volumn 21, Issue 5, 2010, Pages 372-373

Reversible and non-reversible cardiovascular risk in patients treated with lipid-lowering therapy: Analysis of SEAS and JUPITER trials

(2) Poli, A a Corsini, A a

a UNIVERSITY OF MILAN (Italy)

Author keywords

Atherosclerosis; Ezetimibe; Lipid lowering drugs; Statins

Indexed keywords

ANTILIPEMIC AGENT; C REACTIVE PROTEIN; EZETIMIBE PLUS SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; ROSUVASTATIN; SIMVASTATIN;

AGE DISTRIBUTION; AORTA STENOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEATH; DISEASE SEVERITY; DRUG POTENCY; HEART INFARCTION; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; POPULATION RISK; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROTEIN BLOOD LEVEL; REVIEW; RISK REDUCTION; STROKE;

EID: 77956408633 PISSN: 09536205 EISSN: None Source Type: Journal
DOI: 10.1016/j.ejim.2010.04.013 Document Type: Short Survey

Times cited : (8)

References (7)

1
- 0037425746
- Heart Protection Study
- A. Poli, and A. Catapano Heart Protection Study Lancet 361 2003 528
- (2003) Lancet , vol.361 , pp. 528
- Poli, A.¹ Catapano, A.²

2
- 52649120889
- Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
- A.B. Rossebø, T.R. Pedersen, K. Boman, P. Brudi, J.B. Chambers, and K. Egstrup Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
- (2008) N Engl J Med , vol.359 , pp. 1343-1356
- Rossebø, A.B.¹ Pedersen, T.R.² Boman, K.³ Brudi, P.⁴ Chambers, J.B.⁵ Egstrup, K.⁶

3
- 56749106312
- Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
- P.M. Ridker, E. Danielson, F.A. Fonseca, J. Genest, A.M. Gotto Jr., and J.J. Kastelein Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 2008 2195 2207
- (2008) N Engl J Med , vol.359 , pp. 2195-2207
- Ridker, P.M.¹ Danielson, E.² Fonseca, F.A.³ Genest, J.⁴ Gotto, Jr.A.M.⁵ Kastelein, J.J.⁶

4
- 3142687675
- Fluvastatin: Clinical and safety profile
- A. Corsini, T.A. Jacobson, and C.M. Ballantyne Fluvastatin: clinical and safety profile Drugs 64 2004 1305 1323
- (2004) Drugs , vol.64 , pp. 1305-1323
- Corsini, A.¹ Jacobson, T.A.² Ballantyne, C.M.³

5
- 22344458137
- Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
- C. Wanner, V. Krane, W. März, M. Olschewski, J.F. Mann, and G. Ruf Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 2005 238 248
- (2005) N Engl J Med , vol.353 , pp. 238-248
- Wanner, C.¹ Krane, V.² März, W.³ Olschewski, M.⁴ Mann, J.F.⁵ Ruf, G.⁶

6
- 63849163945
- Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
- B.C. Fellström, A.G. Jardine, R.E. Schmieder, H. Holdaas, K. Bannister, and J. Beutler Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
- (2009) N Engl J Med , vol.360 , pp. 1395-1407
- Fellström, B.C.¹ Jardine, A.G.² Schmieder, R.E.³ Holdaas, H.⁴ Bannister, K.⁵ Beutler, J.⁶

7
- 77953233048
- Observed and predicted reduction of ischemic cardiovascular events in the simvastatin and ezetimibe in aortic stenosis trial
- I. Holme, K. Boman, P. Brudi, K. Egstrup, C. Gohlke-Baerwolf, and Y.A. Kesäniemi Observed and predicted reduction of ischemic cardiovascular events in the simvastatin and ezetimibe in aortic stenosis trial Am J Cardiol 105 2010 1802 1808
- (2010) Am J Cardiol , vol.105 , pp. 1802-1808
- Holme, I.¹ Boman, K.² Brudi, P.³ Egstrup, K.⁴ Gohlke-Baerwolf, C.⁵ Kesäniemi, Y.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.